Clinical Trial

A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

Study acronym: MEASUREAAVitHS
Recruiting
View on ClinicalTrials.gov →
Summary
This study is to assess the burden of disease in adolescent and adult participants with moderate or severe alopecia areata (AA), non-segmental vitiligo (NSV), or moderate to severe hidradenitis suppurativa (HS) in a large global real-world participant population.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-08-20; most recent amendment 2026-02-12.
Status change: Not Yet Recruiting → Recruiting 2025-11-11
Trial Details
NCT Number NCT07136467
Lead Sponsor AbbVie
Conditions Non-Segmental Vitiligo (NSV), Alopecia Areata, Hidradenitis Suppurativa
Enrollment 2,795 participants
Start Date 2025-09-02
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-02-13